Peninsula Regional Medical Center and its ALS Clinic welcome ALS patients, their families, caregivers, care providers and anyone interested in learning more about Amyotrophic Lateral Sclerosis to join them for an awareness and educational event on Thursday, September 10.
Rob Goldstein, Vice President of Marketing, Communication and Development for the ALS Therapy Development Institute (ALSTDI), will be the keynote speaker. Goldstein will provide an overview of ALS, the latest in the drug development process and speak to the work of the ALSTDI team’s clinical trials and their Precision Medicine Program.
ALSTDI was founded in 1999. Its scientists actively discover and develop treatments for ALS. It is the world’s first and largest nonprofit biotech focused 100 percent on ALS research. As the organization is led by people and their families who are living with ALS, they understand the urgent need to slow and stop this disease.
The program, with time for questions and answers, is scheduled for an hour and will begin at 5:30 p.m. in the Hallowell Conference Center at PRMC, located on the ground floor of the Layfield Tower. Those attending may park in Garage B and enter through the Frank B. Hanna Outpatient Center. Valet parking will also be available at the Hanna Outpatient Center entrance. Light refreshments will be served. An RSVP is not required.
Anyone with questions concerning the event or learning more about the PRMC ALS Clinic may call Sharon Jernigan at 410-912-2889 or email her at sharon.jernigan@peninsula.org.
